|
| Saturday, November 19, 2011 |
|
| Welcome and Introduction |
Fred Poordad, MD |
 |
|
| Boceprevir Update |
Fred Poordad, MD |
 |
|
| Telaprevir Update |
Kenneth Sherman, MD |
|
|
| Stopping Rules and Resistance |
Andrew J. Muir, MD |
|
|
| Panel Discussion: HIV/HCV, Post OLT, Lead In |
Moderator: Fred Poordad, MD
Panelists:
Robert Gish, MD
Andrew J. Muir, MD
Kenneth Sherman, MD |
|
|
| Panel Discussion: EPO Use, Cirrhotics, IL28B and Other Markers |
Moderator:
Fred Poordad, MD
Panelists:
Robert Gish, MD
Alexander Lee, MD
Kenneth Sherman, MD |
|
|
| Other Emerging Regimens with IFN |
Robert Gish, MD |
|
|
| Interferon Free Regimens |
Fred Poordad, MD |
|
|
| Sunday, November 20, 2011 |
|
| Hepatitis B Face-off: Monotherapy is All You
Need (Steven-Huy Han, MD) vs. Combination
Therapies Need to be Studied (Tram Tran, MD) |
Moderator:
Vandana Khungar, MD |
|
|
| NASH Update: When to Biopsy and What to Do with the Results |
Francisco Durazo, MD |
|
|
| Portal Hypertension; Leaky Gut and Cytokines |
Timothy Morgan, MD |
|
|
| HCC Combination Therapies |
Anthony El-Khoueiry, MD |
|
|
| Debate: 78 Year Old with HCC: Resect or
Transplant (Nicholas Nissen, MD) vs. Non-surgical
Interventions (David Lu, MD) |
Moderator:
Vandana Khungar, MD |
|
|
| Panel Cases: HE Management, Gastric Varices,
HCC: (When is Sorafenib Appropriate?),
HCC Management
|
Moderator:
John Donovan, MD
Panelists:
Francisco Durazo, MD
Anthony El-Khoueiry, MD
Nicholas Nissen, MD |
|
|
